Rajnish Wellness Limited
RAJNISH (BSE 541601) · ISIN INE685Z01033 · Pharmaceuticals · Est. 2015 · listed 2018 · website
Not on any surveillance list
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹102.56 cr | ₹0.17 cr | ₹108.58 cr |
| 30 Sep 2025 standalone | ₹109.13 cr | ₹0 cr | ₹121.31 cr |
| 31 Mar 2025 standalone | ₹84.16 cr | ₹0.18 cr | ₹91.28 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 9.16% | 0.43% | — | 90.84% |
Latest filings
- Scrutiniser report of the vote casted at the 11th AGM held on 26-06-2026 28 September 2026 · BSE
- The 11th Annual General meeting of the members of Rajnish Wellness limited was held on 26th september, 2026 26 September 2026 · BSE
- Notice of the 11th Annual General Meeting of the Company scheduled to be held through VC/OAVM on Saturday the 26th September, 2026 4 September 2026 · BSE
- Annual Report FY2025-26 (New) 4 September 2026 · BSE
- Financial results of the Company for quarter ended on 30th June, 2026 along with Limited Review Report of the statutory Auditor thereon 13 August 2026 · BSE
Other companies in Pharmaceuticals
- Sun Pharmaceutical Industries Limited
- Lupin Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Mankind Pharma Limited
- Aurobindo Pharma Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.